USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 13, 2016 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 13, 2016 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 22, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 20, 2015 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 20, 2015 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 20, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 12, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 17, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 17, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 25, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 9, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 4, 2015 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 19, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 19, 2015 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 19, 2015 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 19, 2015 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 19, 2015 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 13, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 6, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 31, 2014 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of tauopathies; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system for the treatment of inflammatory disorders for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of tauopathies; Pharmaceutical preparations for the treatment and prevention of tauopathies; Pharmaceutical preparations for the treatment of tauopathies; Pharmaceutical preparations for tauopathies
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005